4-Aminobutyrate Aminotransferase (ABAT): Genetic and Pharmacological Evidence for an Involvement in Gastro Esophageal Reflux Disease

• Johan Jirholt ,

  Contributed equally to this work with: Johan Jirholt, Bengt Åsling

  Affiliation AstraZeneca R&D, Mölndal, Sweden

  ⨯
• Bengt Åsling ,

  Contributed equally to this work with: Johan Jirholt, Bengt Åsling

  * E-mail: Bengt.Asling@astrazeneca.com

  Affiliation AstraZeneca R&D, Mölndal, Sweden

  ⨯
• Paul Hammond,

  Affiliation Gastroenterology Unit, Women's & Children's Hospital, North Adelaide, Australia

  ⨯
• Geoffrey Davidson,

  Affiliation Gastroenterology Unit, Women's & Children's Hospital, North Adelaide, Australia

  ⨯
• Mikael Knutsson,

  Affiliation AstraZeneca R&D, Mölndal, Sweden

  ⨯
• Anna Walentinsson,

  Affiliation AstraZeneca R&D, Mölndal, Sweden

  ⨯
• Jörgen M. Jensen,

  Affiliation AstraZeneca R&D, Mölndal, Sweden

  ⨯
• Anders Lehmann,

  Affiliation AstraZeneca R&D, Mölndal, Sweden

  ⨯
• Lars Agreus,

  Affiliation Center for Family and Community Medicine, Karolinska Institutet, Huddinge, Sweden

  ⨯
• Maria Lagerström-Fermer

  Affiliation AstraZeneca R&D, Mölndal, Sweden

  ⨯